US Fabry Disease Market Growth: Opportunities in Gene and Chaperone Therapies The standard of care for Fabry disease is undergoing a paradigm shift. While Enzyme Replacement Therapy (ERT) has been the mainstay for decades, the emergence of new therapeutic modalities is creating significant opportunities for US Fabry Disease Market Growth. With the market projected to expand from USD 511.72 million in 2024 to USD 1.17 billion by 2035 at a CAGR of 7.82%, substantial...
0 Compartilhamentos
344 Visualizações